Pandemic has greatly slowed pace of cancer research

Pandemic has greatly slowed pace of cancer research
By
To the ever-growing list of COVID-19's collateral damage, add one more casualty: cancer research.
A new study indicates that during the first wave of the pandemic last spring, the number of newly launched cancer treatment studies cratered by 60%.
Advertisement
"In short, the first wave of COVID slowed scientific progress in a health-related area distant from the disease itself," said study author Dr. Elizabeth Lamont, senior medical director of Acorn AI, in Boston.
The finding follows a review of data collected by the Medidata Enterprise Data Store, which accounts for nearly 30% of all cancer research.

Related Keywords

Boston ,Massachusetts ,United States ,American ,Richard Schilsky ,Elizabeth Lamont ,Medidata Enterprise Data ,Us Centers For Disease ,American Society Of Clinical Oncology ,Medidata Enterprise Data Store ,American Society ,Disease Control ,Health ,போஸ்டன் ,மாசசூசெட்ஸ் ,ஒன்றுபட்டது மாநிலங்களில் ,அமெரிக்கன் ,எலிசபெத் லாமண்ட் ,எங்களுக்கு மையங்கள் க்கு நோய் ,அமெரிக்கன் சமூகம் ஆஃப் மருத்துவ புற்றுநோயியல் ,அமெரிக்கன் சமூகம் ,நோய் கட்டுப்பாடு ,ஆரோக்கியம் ,